IDYA
Price
$24.33
Change
-$0.04 (-0.16%)
Updated
Aug 15 closing price
Capitalization
2.13B
87 days until earnings call
PMVP
Price
$1.52
Change
-$0.03 (-1.94%)
Updated
Aug 15 closing price
Capitalization
80.55M
82 days until earnings call
Interact to see
Advertisement

IDYA vs PMVP

Header iconIDYA vs PMVP Comparison
Open Charts IDYA vs PMVPBanner chart's image
IDEAYA Biosciences
Price$24.33
Change-$0.04 (-0.16%)
Volume$1.01M
Capitalization2.13B
PMV Pharmaceuticals
Price$1.52
Change-$0.03 (-1.94%)
Volume$256.11K
Capitalization80.55M
IDYA vs PMVP Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. PMVP commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and PMVP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (IDYA: $24.33 vs. PMVP: $1.52)
Brand notoriety: IDYA and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 98% vs. PMVP: 99%
Market capitalization -- IDYA: $2.13B vs. PMVP: $80.55M
IDYA [@Biotechnology] is valued at $2.13B. PMVP’s [@Biotechnology] market capitalization is $80.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, PMVP is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while PMVP’s TA Score has 3 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 4 bearish.
  • PMVP’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than PMVP.

Price Growth

IDYA (@Biotechnology) experienced а +5.32% price change this week, while PMVP (@Biotechnology) price change was +2.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 11, 2025.

PMVP is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.13B) has a higher market cap than PMVP($80.5M). PMVP YTD gains are higher at: 0.662 vs. IDYA (-5.331). PMVP has higher annual earnings (EBITDA): -87.97M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. PMVP (160M). PMVP has less debt than IDYA: PMVP (1.11M) vs IDYA (26M). IDYA has higher revenues than PMVP: IDYA (7M) vs PMVP (0).
IDYAPMVPIDYA / PMVP
Capitalization2.13B80.5M2,648%
EBITDA-356.46M-87.97M405%
Gain YTD-5.3310.662-805%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash693M160M433%
Total Debt26M1.11M2,351%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAPMVP
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 18 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYIEY23.250.19
+0.82%
Symrise Ag
AURWF0.01N/A
N/A
AURWEST RES CORP.
GMALF0.45N/A
N/A
Genting Malaysia Berhad
JFWV105.00N/A
N/A
JSB Financial Inc.
SKUYF8.10N/A
N/A
Sansei Yusoki Co., Ltd.

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-0.16%
IMNM - IDYA
62%
Loosely correlated
+3.42%
SYRE - IDYA
61%
Loosely correlated
+0.53%
CGON - IDYA
61%
Loosely correlated
-1.00%
NRIX - IDYA
61%
Loosely correlated
+0.19%
XENE - IDYA
58%
Loosely correlated
+0.71%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-1.94%
CLLS - PMVP
39%
Loosely correlated
-0.35%
MTVA - PMVP
35%
Loosely correlated
N/A
CMVLF - PMVP
34%
Loosely correlated
N/A
IDYA - PMVP
34%
Loosely correlated
-0.16%
LXEO - PMVP
34%
Loosely correlated
-1.46%
More